View in EDS PDF Full Text

Increased Seroprevalence and Improved Antibody Responses Following Third Primary SARS-CoV-2 Immunisation: An Update From the COV-AD Study.

Saved in:
Bibliographic Details
Title: Increased Seroprevalence and Improved Antibody Responses Following Third Primary SARS-CoV-2 Immunisation: An Update From the COV-AD Study.
Authors: Shields AM; Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.; Department of Clinical Immunology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom., Faustini SE; Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Hill HJ; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Al-Taei S; Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Tanner C; Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Ashford F; Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Workman S; Department of Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom., Moreira F; Department of Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom., Verma N; Department of Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom., Wagg H; Institute of Translational Medicine, University of Birmingham, Birmingham, United Kingdom., Heritage G; Institute of Translational Medicine, University of Birmingham, Birmingham, United Kingdom., Campton N; Institute of Translational Medicine, University of Birmingham, Birmingham, United Kingdom., Stamataki Z; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Drayson MT; Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Klenerman P; Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom., Thaventhiran JED; Medical Research Council Toxicology Unit, University of Cambridge, Cambridge, United Kingdom., Elkhalifa S; Department of Immunology, Salford Royal NHS Foundation Trust, Salford, United Kingdom., Goddard S; Department of Clinical Immunology, University Hospitals North Midlands, Stoke-on-Trent, United Kingdom., Johnston S; Department of Clinical Immunology, North Bristol NHS Trust, Bristol, United Kingdom., Huissoon A; Department of Clinical Immunology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom., Bethune C; Department of Allergy and Clinical Immunology, University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom., Elcombe S; Department of Allergy and Clinical Immunology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, United Kingdom., Lowe DM; Department of Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom.; Institute of Immunity and Transplantation, University College London, London, United Kingdom., Patel SY; Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.; National Institute for Health and Care Research (NIHR) Biomedical Research Centre (BRC) Oxford Biomedical Centre, University of Oxford, Oxford, United Kingdom., Savic S; Department of Allergy and Clinical Immunology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom., Richter AG; Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.; Department of Clinical Immunology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom., Burns SO; Department of Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom.; Institute of Immunity and Transplantation, University College London, London, United Kingdom.
Corporate Authors: COV-AD consortium
Source: Frontiers in immunology [Front Immunol] 2022 Jun 02; Vol. 13, pp. 912571. Date of Electronic Publication: 2022 Jun 02 (Print Publication: 2022).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35720400
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Increased Seroprevalence and Improved Antibody Responses Following Third Primary SARS-CoV-2 Immunisation: An Update From the COV-AD Study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Shields+AM%22">Shields AM</searchLink>; Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.; Department of Clinical Immunology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Faustini+SE%22">Faustini SE</searchLink>; Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Hill+HJ%22">Hill HJ</searchLink>; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Al-Taei+S%22">Al-Taei S</searchLink>; Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Tanner+C%22">Tanner C</searchLink>; Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Ashford+F%22">Ashford F</searchLink>; Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Workman+S%22">Workman S</searchLink>; Department of Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Moreira+F%22">Moreira F</searchLink>; Department of Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Verma+N%22">Verma N</searchLink>; Department of Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Wagg+H%22">Wagg H</searchLink>; Institute of Translational Medicine, University of Birmingham, Birmingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Heritage+G%22">Heritage G</searchLink>; Institute of Translational Medicine, University of Birmingham, Birmingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Campton+N%22">Campton N</searchLink>; Institute of Translational Medicine, University of Birmingham, Birmingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Stamataki+Z%22">Stamataki Z</searchLink>; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Drayson+MT%22">Drayson MT</searchLink>; Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Klenerman+P%22">Klenerman P</searchLink>; Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Thaventhiran+JED%22">Thaventhiran JED</searchLink>; Medical Research Council Toxicology Unit, University of Cambridge, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Elkhalifa+S%22">Elkhalifa S</searchLink>; Department of Immunology, Salford Royal NHS Foundation Trust, Salford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Goddard+S%22">Goddard S</searchLink>; Department of Clinical Immunology, University Hospitals North Midlands, Stoke-on-Trent, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Johnston+S%22">Johnston S</searchLink>; Department of Clinical Immunology, North Bristol NHS Trust, Bristol, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Huissoon+A%22">Huissoon A</searchLink>; Department of Clinical Immunology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Bethune+C%22">Bethune C</searchLink>; Department of Allergy and Clinical Immunology, University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Elcombe+S%22">Elcombe S</searchLink>; Department of Allergy and Clinical Immunology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Lowe+DM%22">Lowe DM</searchLink>; Department of Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom.; Institute of Immunity and Transplantation, University College London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Patel+SY%22">Patel SY</searchLink>; Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.; National Institute for Health and Care Research (NIHR) Biomedical Research Centre (BRC) Oxford Biomedical Centre, University of Oxford, Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Savic+S%22">Savic S</searchLink>; Department of Allergy and Clinical Immunology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Richter+AG%22">Richter AG</searchLink>; Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.; Department of Clinical Immunology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Burns+SO%22">Burns SO</searchLink>; Department of Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom.; Institute of Immunity and Transplantation, University College London, London, United Kingdom.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22COV-AD+consortium%22">COV-AD consortium</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2022 Jun 02; Vol. 13, pp. 912571. <i>Date of Electronic Publication: </i>2022 Jun 02 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35720400
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2022.912571
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 912571
    Titles:
      – TitleFull: Increased Seroprevalence and Improved Antibody Responses Following Third Primary SARS-CoV-2 Immunisation: An Update From the COV-AD Study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Shields AM
      – PersonEntity:
          Name:
            NameFull: Faustini SE
      – PersonEntity:
          Name:
            NameFull: Hill HJ
      – PersonEntity:
          Name:
            NameFull: Al-Taei S
      – PersonEntity:
          Name:
            NameFull: Tanner C
      – PersonEntity:
          Name:
            NameFull: Ashford F
      – PersonEntity:
          Name:
            NameFull: Workman S
      – PersonEntity:
          Name:
            NameFull: Moreira F
      – PersonEntity:
          Name:
            NameFull: Verma N
      – PersonEntity:
          Name:
            NameFull: Wagg H
      – PersonEntity:
          Name:
            NameFull: Heritage G
      – PersonEntity:
          Name:
            NameFull: Campton N
      – PersonEntity:
          Name:
            NameFull: Stamataki Z
      – PersonEntity:
          Name:
            NameFull: Drayson MT
      – PersonEntity:
          Name:
            NameFull: Klenerman P
      – PersonEntity:
          Name:
            NameFull: Thaventhiran JED
      – PersonEntity:
          Name:
            NameFull: Elkhalifa S
      – PersonEntity:
          Name:
            NameFull: Goddard S
      – PersonEntity:
          Name:
            NameFull: Johnston S
      – PersonEntity:
          Name:
            NameFull: Huissoon A
      – PersonEntity:
          Name:
            NameFull: Bethune C
      – PersonEntity:
          Name:
            NameFull: Elcombe S
      – PersonEntity:
          Name:
            NameFull: Lowe DM
      – PersonEntity:
          Name:
            NameFull: Patel SY
      – PersonEntity:
          Name:
            NameFull: Savic S
      – PersonEntity:
          Name:
            NameFull: Richter AG
      – PersonEntity:
          Name:
            NameFull: Burns SO
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 06
              Text: 2022 Jun 02
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 13
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1